Skip to search.
 TSX Up 1.00% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On TKM.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Tekmira Pharmaceuticals Corporation (TKM.TO)

-Toronto
15.51 Up 1.55(11.10%) 4:00PM EDT
Add to Portfolio
Prev Close:13.96
Open:14.50
Bid:15.40
Ask:15.59
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:14.32 - 15.80
52wk Range:4.58 - 34.66
Volume:395,011
Avg Vol (3m):138,332
Market Cap:305.38M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.54
Quarterly EPS Est (Mar-14) :0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback